scorecardresearch
Add as a preferred source on Google
Sunday, March 15, 2026
TopicBiocon

Topic: Biocon

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

CBI alleges bribery in Biocon injection clearance, company says ‘approvals legitimate’

In a statement Monday, Biocon Biologics spokesperson said the injection is approved in Europe & many other countries. CBI has booked joint drug controller, Biocon executives in the case.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

Monitor efficacy of Itolizumab, not just safety, in Covid trials — expert panel tells Biocon

Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon to give more data on Itolizumab to Covid task force after its rejection for treatment

The company said it would share more data as ‘evidence’, which it has derived from off-label use of the drug on 1,000 patients.

30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab

The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

On Camera

Gulf conflict pushes Dubai diamond traders to eye Surat for rough stone auctions. But there are hurdles

Industry leaders say India’s complicated customs process and GST levies are deterrents for traders to come to Surat for auctions.

Supreme Leader Mojtaba, the man Iran must keep alive & the secret force ‘tasked with it’—all about NOPO

The Nirouyeh Vijeh Pasdaran Velayat, or NOPO, was the only force Ali Khamenei trusted.It was founded in 1991 and is more feared than the Revolutionary Guards.

Peaceful power transfers followed uprisings in India’s neighbourhood. It’s a sign of mature democracies

Rating democracies is a tricky business. I am only using the simple metric of who in the Indian subcontinent has had the most peaceful, stable, normal political transitions and continuity.